In an era when Washington seems incapable of finding common ground on virtually any issue, it’s notable to encounter a policy area where stakeholders across the political spectrum agree. Gene ...
The biosecurity risks associated with an unregulated industry became evident when, in 2006, a Guardian reporter successfully ordered parts of the smallpox genome through the mail. Although ordering ...
CD Bioparticles launches specialized RNA Synthesis services for researchers to develop next-generation mRNA vaccines, gene therapies, and RNA-based therapeutics.
The Wyss Institute for Biologically Inspired Engineering at Harvard University is partnering with Northpond Labs to launch the RNA synthesis company EnPlusOne Biosciences (EnPlusOne Bio). EnPlusOne ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results